Literature DB >> 35015823

Use of Linked Databases for Improved Confounding Control: Considerations for Potential Selection Bias.

Jenny W Sun, Rui Wang, Dongdong Li, Sengwee Toh.   

Abstract

Pharmacoepidemiologic studies are increasingly conducted within linked databases, often to obtain richer confounder data. However, the potential for selection bias is frequently overlooked when linked data is available only for a subset of patients. We highlight the importance of accounting for potential selection bias by evaluating the association between antipsychotics and type 2 diabetes in youths within a claims database linked to a smaller laboratory database. We used inverse probability of treatment weights (IPTW) to control for confounding. In analyses restricted to the linked cohorts, we applied inverse probability of selection weights (IPSW) to create a population representative of the full cohort. We used pooled logistic regression weighted by IPTW only or IPTW and IPSW to estimate treatment effects. Metabolic conditions were more prevalent in linked cohorts compared with the full cohort. Within the full cohort, the confounding-adjusted hazard ratio was 2.26 (95% CI: 2.07, 2.49) comparing initiation of antipsychotics with initiation of control medications. Within the linked cohorts, a different magnitude of association was obtained without adjustment for selection, whereas applying IPSW resulted in point estimates similar to the full cohort's (e.g., an adjusted hazard ratio of 1.63 became 2.12). Linked database studies may generate biased estimates without proper adjustment for potential selection bias.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  health-care databases; linked data; pharmacoepidemiology; selection bias

Mesh:

Year:  2022        PMID: 35015823      PMCID: PMC9430441          DOI: 10.1093/aje/kwab299

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   5.363


  44 in total

1.  A structural approach to selection bias.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; James M Robins
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

Review 2.  Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.

Authors:  Marc De Hert; Johan Detraux; Ruud van Winkel; Weiping Yu; Christoph U Correll
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

3.  Invited Commentary: Selection Bias Without Colliders.

Authors:  Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2017-06-01       Impact factor: 4.897

4.  Development and validation of algorithms to identify newly diagnosed type 1 and type 2 diabetes in pediatric population using electronic medical records and claims data.

Authors:  Dana Y Teltsch; Soulmaz Fazeli Farsani; Richard S Swain; Stefan Kaspers; Samuel Huse; Christina Cristaldi; Beth L Nordstrom; Kimberly G Brodovicz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-01-24       Impact factor: 2.890

5.  From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources.

Authors:  Gianluca Trifirò; Janet Sultana; Andrew Bate
Journal:  Drug Saf       Date:  2018-02       Impact factor: 5.606

6.  Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.

Authors:  Stephen R Cole; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2010-06-14       Impact factor: 4.897

7.  Estimation of biomarker distributions using laboratory data collected during routine delivery of medical care.

Authors:  Maurice Alan Brookhart; Jonathan V Todd; Xiaojuan Li; B Diane Reams; Virginia Pate; Abhijit V Kshirsagar
Journal:  Ann Epidemiol       Date:  2014-08-06       Impact factor: 3.797

8.  Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records.

Authors:  Krista F Huybrechts; Chandrasekar Gopalakrishnan; Jessica M Franklin; Kristina Zint; Lionel Riou Franca; Dorothee B Bartels; Joan Landon; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2018-11-11       Impact factor: 6.875

9.  Extending inferences from a randomized trial to a new target population.

Authors:  Issa J Dahabreh; Sarah E Robertson; Jon A Steingrimsson; Elizabeth A Stuart; Miguel A Hernán
Journal:  Stat Med       Date:  2020-04-06       Impact factor: 2.373

10.  Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model.

Authors:  Moa P Lee; Robert J Glynn; Sebastian Schneeweiss; Kueiyu Joshua Lin; Elisabetta Patorno; Julie Barberio; Raisa Levin; Thomas Evers; Shirley V Wang; Rishi J Desai
Journal:  Clin Epidemiol       Date:  2020-06-15       Impact factor: 4.790

View more
  1 in total

1.  Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan.

Authors:  Chien-Ning Hsu; Kelly Huang; Fang-Ju Lin; Huang-Tz Ou; Ling-Ya Huang; Hsiao-Ching Kuo; Chi-Chuan Wang; Sengwee Toh
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.